The Number of Americans Skipping Scripts Jumped Between 2023 and 2025, KFF Poll Finds
And three more medicines -- Novartis’ Mayzent, Rydapt, and Tabrecta -- have been added to TrumpRx
Mar 13, 2026
Subscribe to Cost Curve Apex to read the rest.
Upgrade to Apex to get access to this post and other subscriber-only content.
Upgrade